603520 Zhejiang Starry Pharmaceutical
- 12.42
- +0.07+0.57%
Zhejiang Starry Pharmaceutical News
Announcement of Si Taili on the use of idle raised funds for cash management due and redemption
Stai Li: Stai Li's 2021 Annual Equity Distribution Implementation Notice
Stary's 2021 Annual Equity Distribution Implementation Notice
Stary's announcement on the use of idle raised funds for cash management and maturity redemption
Announcement by Stai Li on the company\'s proposed purchase of land use rights
Stary\'s announcement on the use of idle raised funds for cash management and maturity redemption
Stary's announcement on the use of idle raised funds for cash management and maturity redemption
Stary's announcement on the use of idle raised funds for cash management and maturity redemption
Stary's announcement on the use of idle raised funds for cash management and maturity redemption
Stary Stary: Announcement on the sale of some vacant properties
Stary Li: Explanation on voting against the proposal relating to the issuance of convertible corporate bonds by Stary Li
Stary Li: Rules for convertible corporate bond holders' meetings
Stai Li: Announcement on the completion of asset transfers for major asset purchases and related transactions
Stai Li: Report on Major Asset Purchases and Related Transactions (Draft) (Revised Draft)
Stai Li: Major Asset Purchase and Related Transaction Report (Draft) Summary (Revised Draft)
Stai Li: Major Asset Purchase and Related Transaction Report (Draft) Summary
Stai Li: Report on Major Asset Purchases and Related Transactions (Draft)
Analysis
Price Target
No Data
